NEWS

NEWS TYPE
RELEASE YEAR

ANNOUNCEMENT

WPI-Bio2Q international collaborator Akiko Iwasaki appears on two Time 100 lists

May 7, 2024

WPI-Bio2Q international collaborator Akiko Iwasaki has been named to both the TIME100 and TIME100 Health.

Yale school of medicine

May 02, 2024 by Rob Forman

 

Iwasaki Appears on Two “Time100” Lists

 

Twice in the past month, Time Magazine has named Yale School of Medicine scientist Akiko Iwasaki, PhD, to one of its prestigious “Time100” lists.

 

On April 17, Time featured Iwasaki, who is Sterling Professor of Immunobiology and professor of dermatology; of molecular, cellular & developmental biology; and of epidemiology (microbial diseases), on its list of “the 100 most influential people of 2024,” which included leading figures in a variety of fields including the arts, entertainment, world politics, and the group that highlighted Iwasaki — innovators.

 

In praising Iwasaki, Anthony Fauci, MD, former director of the National Institute of Allergy and Infectious Diseases, wrote in Time that “she is at the top of her game. Her deep appreciation of the regulation of the human immune system has allowed her to lead the way in delineating the mechanisms of how it reacts to COVID-19, and the consequences of Long COVID.”

 

On May 2, a second list featured Iwasaki — this one devoted to the 100 most influential people in health. The magazine described the group as “a community of leaders from across industries — scientists, doctors, advocates, educators, and policy-makers, among others — dedicated to creating tangible, credible change for a healthier population.”

 

In recognizing Iwasaki in its category called “leaders,” Time noted her work toward being able to administer COVID-19 vaccines through the nose, the part of the body through which the virus often enters and where vaccines may offer the best protection. Time also cited Iwasaki’s efforts toward solving the mysteries of post-infection diseases like Long COVID. Of her work on treating and preventing Long COVID symptoms, and also on the disease’s basic biology, Iwasaki told Time that she is in it for the long haul. “It’s not going to be solved overnight,” she said, “but I’m committed to doing it.”

 

https://medicine.yale.edu/news-article/iwasaki-appears-on-two-time100-lists/

 

More Bio2Q News

EVENT
2024.05.17

WPI-Bio2Q Open Seminar to be held on June 12

On Wednesday, June 12, the Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q)  will hold an open seminar at Shinan...

ANNOUNCEMENT
2024.05.07

What is WPI-Bio2Q? (WPI-Bio2Q Promotional Video)

The World Premier International Research Center Initiative (WPI) was launched in 2007 by MEXT in a drive to build within Japan “globally vis...

EVENT
2024.04.30

WPI-Bio2Q Open Seminar by Dr. Daniel Mende held on April 25

On Monday,  April 25, the Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar at Shinanomachi ...

RESEARCH
2024.04.18

Keio University WPI-Bio2Q Publication

A lipidome landscape of aging in mice Nature Aging (2024) Published: 12 April 2024 DOI: 10.1038/s43587-024-00610-6 Hiroshi Tsugawa...

ANNOUNCEMENT
2024.04.16

Bio2Q Members - Dr. Vinodh Joseph

It is our pleasure to introduce  our new member, Dr. Vinodh Joseph, a postdoctoral fellow at Bio1 core of Bio2Q.